Latest Articles

Publication Date
All News Scientific
Ananda Pharma's MRX1 moves closer to clinical trials after key milestone - Proactive Investors UK

Ananda Pharma's MRX1 moves closer to clinical trials after key milestone Proactive Investors UK

Published: Feb. 20, 2025, 3:20 p.m.
Read Full Article
Endometriosis imaging agent impresses at clinical trials - Health Imaging

Endometriosis imaging agent impresses at clinical trials Health Imaging

Published: Feb. 10, 2025, 12:39 p.m.
Read Full Article
Endometriosis Clinical Trials and Studies 2025: EMA, PDMA, FDA - openPR

Endometriosis Clinical Trials and Studies 2025: EMA, PDMA, FDA openPR

Published: Feb. 6, 2025, 7:24 p.m.
Read Full Article
Endometriosis Clinical Trial Pipeline Gains Momentum as 15+ Key Companies at the Forefront | DelveInsight - The Malaysian Reserve

Endometriosis Clinical Trial Pipeline Gains Momentum as 15+ Key Companies at the Forefront | DelveInsight The Malaysian Reserve

Published: Jan. 29, 2025, 11:29 p.m.
Read Full Article
DelveInsight Business Research, LLP: Endometriosis Clinical Trial Pipeline Gains Momentum as 15+ Key Companies at the Forefront | DelveInsight - finanznachrichten.de

DelveInsight Business Research, LLP: Endometriosis Clinical Trial Pipeline Gains Momentum as 15+ Key Companies at the Forefront | DelveInsight finanznachrichten.de

Published: Jan. 29, 2025, 10:36 p.m.
Read Full Article
Endometriosis Clinical Trial Pipeline Gains Momentum as 15+ Key Companies at the Forefront | DelveInsight - PR Newswire

Endometriosis Clinical Trial Pipeline Gains Momentum as 15+ Key Companies at the Forefront | DelveInsight PR Newswire

Published: Jan. 29, 2025, 10:31 p.m.
Read Full Article
Endometriosis Pipeline 2024: Detailed Clinical Trials - openPR

Endometriosis Pipeline 2024: Detailed Clinical Trials openPR

Published: Jan. 16, 2025, 6:40 p.m.
Read Full Article
Press Release Service: Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial - CRISPR Medicine News

Press Release Service: Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial CRISPR Medicine News

Published: Dec. 13, 2024, 12:56 p.m.
Read Full Article
Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial - BioSpace

Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial BioSpace

Published: Dec. 12, 2024, 11:25 p.m.
Read Full Article
IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer - BioSpace

IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer BioSpace

Published: Dec. 10, 2024, 12:23 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!